RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
75 hedge funds and large institutions have $107M invested in Regulus Therapeutics in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 28 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.67% more ownership
Funds ownership: 81.69% → 82.36% (+0.67%)
39% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 28
Holders
75
Holding in Top 10
–
Calls
$299K
Puts
$28K
Top Buyers
| 1 | +$7.35M | |
| 2 | +$4.71M | |
| 3 | +$1.88M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.68M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$792K |
Top Sellers
| 1 | -$4.03M | |
| 2 | -$3.46M | |
| 3 | -$3.16M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$532K |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$371K |
